In a nutshell, I am a passionate and ambitious life-science marketing strategist, advisor, and entrepreneur. Now the long story. In 2008, I started my first business, an industry agnostic marketing consultancy. Life happened, and in 2011, I embarked on a journey into a very different kind of marketing: the world of life-science marketing. Highly regulated and conservative, it ties your hands with claims, data, references, footnotes, earning doctors' trust, and safeguarding patient lives. No pressure. I’m reminded every day about the importance of my job. There is a great responsibility in being a ‘pharma marketer’ and helping pharmaceutical companies communicate accurate medical information about therapeutics or diseases, to health care professionals (HCPs) and patients. Lives may depend on how well we tell stories with medical information across different channels, via various digital and print assets. It’s scary, humbling, yet so empowering to be part of teams that shape something as sacred as health. One of the most special aspects of working in the life-sciences is the opportunity to get a sneak peak of the future. Research. Discoveries. New drugs. Clinical trials. New drug launches. All of this, leading to my awe and dedication to help biotech start-ups bring the future faster to all of us. I’ll be honest. There is a pattern. A world-class scientist discovers something revolutionary, forms a company with the goal of getting a drug or other therapeutic product to the market. At some point, they realize that great science alone is not enough. Investors don't get the story, progress isn't happening overnight. This is where I like to bring in my experience and know-how, and help them tell a compelling story, on the one-pager, in the pitch deck, on the website, in social media. Today, through my consulting business and a stealth mode SaaS start up, I’m on a quest to help life-science companies transform how they do marketing. Rethink content authoring. Rethink data visualization. Rethink creative. Rethink channels. Rethink the medical / legal / regulatory review process. Rethink content delivery. Rethink what to do with data. Rethink everything. Then reimagine.
Managing Partner at The Naissos Group
Executive MBA